isomethyleugenol has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, AK; Chu, T; DiStefano, EW; Kumagai, Y | 1 |
| Callery, PS; Kaplan, JA; Kraner, JC; Shakleya, DM | 1 |
| Bomsien, S; Skopp, G | 1 |
| Crété, D; Debray, M; Declèves, X; Fonsart, J; Galons, H; Menet, MC; Noble, F; Scherrmann, JM | 1 |
| Maurer, HH; Meyer, MR | 1 |
| Cockburn, AK; Livingstone, AC; Maskell, PD; Pounder, DJ; Preece, J; Seetohul, LN | 1 |
6 other study(ies) available for isomethyleugenol and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Dose-Response Relationship, Drug; Female; Hallucinogens; Male; Methylation; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; Serotonin; Sex Factors; Species Specificity; Stereoisomerism | 1996 |
Methylation of 3,4-methylenedioxymethamphetamine in formalin-fixed human liver tissue.
Topics: Embalming; Fixatives; Forensic Pathology; Formaldehyde; Humans; Liver; Methylation; N-Methyl-3,4-methylenedioxyamphetamine; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tissue Fixation | 2005 |
An in vitro approach to potential methadone metabolic-inhibition interactions.
Topics: Algorithms; Amitriptyline; Analgesics, Opioid; Atomoxetine Hydrochloride; Chromatography, Liquid; Citalopram; Clozapine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Isoenzymes; Kinetics; Methadone; Methylation; N-Methyl-3,4-methylenedioxyamphetamine; Oxidoreductases, N-Demethylating; Propylamines; Psychotropic Drugs; Pyridines; Pyrrolidines; Tandem Mass Spectrometry; Zolpidem | 2007 |
Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Topics: Animals; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Dose-Response Relationship, Drug; Female; Hallucinogens; Lethal Dose 50; Male; Methylation; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Sex Characteristics | 2008 |
Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.
Topics: 3,4-Methylenedioxyamphetamine; Biocatalysis; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catechols; Cytochrome P-450 Enzyme System; Designer Drugs; Dopamine; Enzyme Inhibitors; Gas Chromatography-Mass Spectrometry; Humans; Kinetics; Methylation; Microsomes, Liver; N-Methyl-3,4-methylenedioxyamphetamine; Stereoisomerism | 2009 |
Stability of 3,4-methylenedioxymethampetamine (MDMA), 4-methylmethcathinone (mephedrone) and 3-trifluromethylphenylpiperazine (3-TFMPP) in formalin solution.
Topics: Calibration; Chromatography, High Pressure Liquid; Designer Drugs; Drug Stability; Formaldehyde; Hallucinogens; Hydrogen-Ion Concentration; Indicators and Reagents; Mass Spectrometry; Methamphetamine; Methylation; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Quality Control; Reference Standards; Reproducibility of Results; Serotonin Receptor Agonists; Solutions | 2013 |